Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/14/05 → 8/10/10 |
Funding
- Coley Pharmaceutical Group, Inc. (CPG 10101-003)
Prot# CPG 10101-003: CPG 10101 Combination Therapy for the Treatment of Hepatitis C: A Phase 1B Open Label Randomized Trial of CPG 10101 Alone, with Interferon, Ribavirin, or Interferon and Ribavirin in the Treatment of Relapsed HCV Subjects
- Flamm, Steven L (PD/PI)
Project: Research project